TGFB1 and hydrops fetalis: This SGLT2i mechanism of action is particularly interesting, as it has been well documented in animal studies, that inhibition of the TGF-Beta1/Smad3 signalling pathway significantly inhibits myocardial fibrosis and left ventricular remodelling in HF regardless of the presence of diabetes.